Literature DB >> 21522013

The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology.

Justyna D Kowalska1, Nina Friis-Møller, Ole Kirk, Wendy Bannister, Amanda Mocroft, Caroline Sabin, Peter Reiss, John Gill, Charlotte Lewden, Andrew Phillips, Antonella D'Arminio Monforte, Matthew Law, Jonathan Sterne, Stephane De Wit, Jens D Lundgren.   

Abstract

BACKGROUND: The Coding Causes of Death in HIV (CoDe) Project aims to deliver a standardized method for coding the underlying cause of death in HIV-positive persons, suitable for clinical trials and epidemiologic studies.
METHODS: The project incorporates detailed data collection, a classification system, and a centralized adjudication process performed by 2 independent reviewers. The methodology was tested in the Data Collection on Adverse events of Anti-HIV Drugs Study , and independent reviews of causes of death were compared. Logistic regression models identified factors associated with initial agreement by reviewers on underlying cause of death.
RESULTS: A total of 491 reported fatal cases were adjudicated; in only 5% of cases the cause of death remained undetermined after adjudication. Reviewers initially agreed on the underlying cause for 339 (69%) deaths. As compared with deaths due to AIDS-related causes, the odds of agreement were more than 80% lower when deaths were ultimately deemed to be due to non-AIDS-related causes (odds ratio = 0.17 [95% confidence interval = 0.08-0.37]) or undetermined causes (0.11 [0.04-0.36]). The odds of initial agreement were also lower for deaths occurring in subjects with hypertension (0.43 [0.22-0.85]) and depression (0.43 [0.23-0.80]).
CONCLUSIONS: The extent and format of data collected in the CoDe Project appear to be sufficient for an informed review, and the proposed coding scheme is adequate for obtaining an underlying cause of death.

Entities:  

Mesh:

Year:  2011        PMID: 21522013     DOI: 10.1097/EDE.0b013e31821b5332

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  60 in total

1.  Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program.

Authors:  Rachel M Wake; Nelesh P Govender; Tanvier Omar; Carolina Nel; Ahmad Haeri Mazanderani; Aaron S Karat; Nazir A Ismail; Caroline T Tiemessen; Joseph N Jarvis; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

2.  Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula.

Authors:  Jessie K Edwards; Stephen R Cole; Richard D Moore; W Christopher Mathews; Mari Kitahata; Joseph J Eron
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

3.  Examining Mortality to Identify Opportunities for Improved Care Among Adults with HIV in a Single Academic Medical Center.

Authors:  Adam M Ressler; Mona Abdo; Samantha MaWhinney; Steven C Johnson; Kristine M Erlandson
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-23       Impact factor: 2.205

4.  The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis.

Authors:  Álvaro H Borges; Jacqueline Neuhaus; Shweta Sharma; James D Neaton; Keith Henry; Olga Anagnostou; Teresa Staub; Sean Emery; Jens D Lundgren
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

5.  Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.

Authors:  Helen Kovari; Caroline A Sabin; Bruno Ledergerber; Lene Ryom; Signe W Worm; Colette Smith; Andrew Phillips; Peter Reiss; Eric Fontas; Kathy Petoumenos; Stéphane De Wit; Philippe Morlat; Jens D Lundgren; Rainer Weber
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

6.  Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality.

Authors:  Angie N Pinto; Pat Grey; Ansari Shaik; David A Cooper; Anthony D Kelleher; Kathy Petoumenos
Journal:  AIDS Res Hum Retroviruses       Date:  2018-07-17       Impact factor: 2.205

7.  Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.

Authors:  Álvaro H Borges; Jemma L O'Connor; Andrew N Phillips; James D Neaton; Birgit Grund; Jacqueline Neuhaus; Michael J Vjecha; Alexandra Calmy; Kersten K Koelsch; Jens D Lundgren
Journal:  J Infect Dis       Date:  2016-04-30       Impact factor: 5.226

8.  Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989-2012.

Authors:  Nikoloz Chkhartishvili; Lali Sharvadze; Otar Chokoshvili; Natalia Bolokadze; Nino Rukhadze; Russell R Kempker; Amiran Gamkrelidze; Jack A DeHovitz; Carlos Del Rio; Tengiz Tsertsvadze
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-24       Impact factor: 2.205

9.  Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?

Authors:  Brian B Hart; Anna D Nordell; Jason F Okulicz; Adrian Palfreeman; Andrzej Horban; Eynat Kedem; Jacqueline Neuhaus; David R Jacobs; Daniel A Duprez; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2018-01-01       Impact factor: 3.731

10.  Causes of death in HIV-infected patients from the Cologne-Bonn cohort.

Authors:  K Ehren; C Hertenstein; T Kümmerle; J J Vehreschild; J Fischer; D Gillor; C Wyen; C Lehmann; O A Cornely; N Jung; S Gravemann; M Platten; J C Wasmuth; J K Rockstroh; C Boesecke; C Schwarze-Zander; G Fätkenheuer
Journal:  Infection       Date:  2013-10-01       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.